Disclaimer
You agree that the following disclaimer, which is more complete than the brief disclamer on the individual webpages of this website, shall be the full legal disclaimer that shall govern the use of any information obtained by you from discpainbreakthrough.com. The medical information on this website is for educational purposes, to provide general information regarding certain new research developments in medicine. In the interest of public eduation several of these developments have been reported here as soon as possible after their publication. The information on this website should not be considered complete, nor should it be relied upon to establish or suggest a course of treatment for any particular individual. Although efforts will be made from time to time to update this information, it cannot be considered to be up-to-date, but rather to be only a partial report of the medical and research information available at the time this was written. The opinions presented on this website are subject to change, and should not be considered to be a treatment recommendation for any individual patient. Treatment recommendations can only be made in the course of an established physician-patient relationship following an in-person physical examination, medical history, and review of medical records. The information in this website should therefore not be used in place of a visit to your physician. Consult with your personal physician before beginning a new treatment regimen. You, the reader, take sole responsibility for interpretation and application of the information in this website. Mechanisms of disease remain incompletely understood and subject to constant revision as medical knowledge is developed. Medical opinions differ, and no representation is made that the information on this website represents current medical opinion or the standard of medical care. See California B&P 2234.1(4c): "Since the National Institute of Medicine has reported that it can take up to 17 years for a new best practice to reach the average physician and surgeon, it is prudent to give attention to new developments not only in general medical care but in the actual treatment of specific diseases, particularly those that are not yet broadly recognized in California".
All medications have potential
adverse effects. These side effects must be weighed against the
possibility of beneficial therapeutic effects with regard to treatment
of the underlying illnesses in question. Biologic TNF inhibitors
have been associated with serious adverse reactions. Readers are
referred to the prescribing information available from the pharmaceutical
manufacturers for more complete information. This is generally
available in the patient handouts accompanying the medications;
from pharmacies; in the PDR; and on the manufacturer websites.
The treatments used at our medical clinics are generally for clinical
disorders for which currently available treatments are either
ineffective, only partially effective, or associated with other
adverse effects. Neither our physicians, nor any of our employees
or agents can guarantee that treatment at our clinics will result
in clinical improvement and will not result in adverse effects.
The information included in this website is for general informational
and educational use only, and is subject to change pending the
results of additional studies or additional clinical results reported
in the medical literature. The information contained in this website
is not meant to substitute for the opinion of the patient's personal
physician, and should not be construed as a treatment recommendation.
Treatment recommendations can only be given after an in-office
evaluation by an INR physician. Any recommendations regarding
treatment must be viewed in the context of the treatment literature
and discussions which take place during the in-office evaluation
by one of our physicians, with particular consideration to the
fact that many medications used at our clinics, while FDA approved
for other uses, have not received FDA approval for the off-label
indication selected by our physician. Off-label status of a drug
or biologic means, by definition, that this medication has not
been endorsed by the FDA to be either safe or effective for this
off-label use, even if the medication has been FDA-approved for
other medical uses. We cannot guarantee, nor do we mean to imply,
by any of the information in this website, that any single medication
will necessarily lead to clinical improvement if administered
for any given new patient. Screening or physician evaluation at
the Institute for Neurological Research, a private medical group,
inc. does not guarantee that treatment will be recommended or
undertaken by the Institute physician. Treatment decisions will
be made individually. Contraindications to medical treatment at
the Institute may be determined at any stage in the evaluation
process, even prior to physician physical examination.
General
Issues
Information in this website should not be interpreted as a recommendation
to buy or sell any securities.
Indemnification
You agree to indemnify, defend, and hold harmless the Institute for Neurological Research, a private medical group, inc., from and against all damages and costs, including all losses, expenses and reasonable attorney's fees, resulting from any violation of this agreement by you or any of your agents or any activity related to your use of this website (including infringement of third parties United States or worldwide intellectual property rights or negligent or wrongful conduct) by you or your agent.You agree that the Institute for Neurological Research, a private medical group, inc., shall not have any liability to you under any theory of liability or indemnity in connection with your use of discpainbreakthrough.com.Notwithstanding the foregoing paragraph, the total liability of Institute for Neurological Research, a private medical group, inc., shall not exceed the fees paid by the user for the particular information or service provided.
Return
to Home Page